Supplemental Table 4 from Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer

Read full text Summarise with VIRAT
Authors: Sarah K. Herzog, Jessica H. Stevens, Guowei gu, Sandra L. Grimm, Kloma T Cardoza, Autumn G.M. Hawkins, Hangqing Lin, Daniela Ramos, Amanda R. Beyer, David G. Edwards, Derek J. Dustin, Harry J. Yang
+7 more Nicole Liang, Ashfia Fatima Khan, Tasneem Bawa-Khalfe, Daniel James McGrail, Shiaw‐Yih Lin, Cristian Coarfa, Suzanne A.W. Fuqua
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Overrepresentation analysis enrichment of MSigDB KEGG and HALLMARK pathways in the ESR1m defective RSR signature

Fields of Study & Subjects

Estrogen and related hormone effects Breast Cancer Treatment Studies Advanced Breast Cancer Therapies

Publication details

Publication date
2 April 2026
Language
EN